Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Infection by closely related HIV strains possible

28.11.2002


A report of an individual infected with a second strain of HIV despite effective drug treatment following the first infection has researchers concerned.



"For the first time, we’ve shown it is possible for an individual to become infected with two closely related strains of HIV," says Bruce D. Walker, M.D., a grantee of the National Institute of Allergy and Infectious Diseases (NIAID) and a researcher at Massachusetts General Hospital and Harvard Medical School.

Published in this week’s issue of Nature, these findings underscore the challenges vaccine developers face in creating a broadly effective vaccine against HIV. The first HIV vaccines may not prevent infection altogether, but rather may prevent HIV from causing disease by limiting the virus’ ability to reproduce, explains Dr. Walker. This case shows that a hypothetical vaccine against one strain of HIV may not necessarily protect the vaccinee against other, closely related strains.


"The implications of superinfection for an individual with HIV/AIDS are not yet clear," says Anthony S. Fauci, M.D., NIAID’s director. "However, there is little doubt what these new data mean in terms of public health: It is imperative that safer sex be practiced during each encounter, even when both partners are HIV-infected," he adds.

The new case involves a person whose HIV infection was kept in check for many months during structured treatment interruption (STI). In STI, antiviral therapies are frequently given during the early, acute stage of infection, but halted after the immune system has had time to adapt to the virus. Often, as in this case, a patient’s immune system rebounds enough to keep HIV suppressed. "This patient’s immune response against HIV was really quite robust," says Dr. Walker. Thus, the researchers were perplexed when, after successfully suppressing HIV for close to one year, the patient’s viral load suddenly shot upwards. Despite several more attempts to interrupt therapy, the patient was unable to hold the virus to previously attained low levels.

To understand why STI stopped working for this individual, "We dissected the immune system in very fine detail," says Dr. Walker. First, he and his co-investigators examined HIV-made proteins taken from the patient at several points in time. They detected a difference between the amino acid sequence of the original infecting virus and the virus isolated after STI failed. Additional studies confirmed that the change resulted from infection by a second HIV strain well after the first infection.

The two strains differed in overall amino acid sequence by about 12 percent, "about what we’d expect for two strains in North America," notes Dr. Walker. In comparison, the sequence difference between strains of various major subtypes, or clades, of HIV is about 30 percent. Although superinfection by strains from different clades has been reported previously, this is the first published report of infection by two strains from the same clade.

The picture became still more sobering when the researchers compared only those HIV amino acid sequences targeted by the immune system. Here, the strains differed by 50 percent. Consequently, a large fraction of the immune cells that had been produced previously and that had successfully tamped down the first virus were unable to recognize and react to the second strain. "We were stunned," says Dr. Walker. "Essentially, the immune system was encountering two markedly different viruses."

The research did uncover a few bright spots, however. For instance, immune system cells called CD8+ T cells, appeared in new, strain-specific forms after the individual became infected with the second strain. This indicates an ability on the part of the CD8+ T cells to react appropriately to newly arrived HIV strains, even in conditions of chronic infection. Thus, researchers can remain cautiously optimistic that therapeutic immunization to create broader and more potent immune responses in persons with chronic HIV infection may one day be possible.


NIAID is a component of the National Institutes of Health (NIH), which is an agency of the Department of Health and Human Services. NIAID supports basic and applied research to prevent, diagnose, and treat infectious and immune-mediated illnesses, including HIV/AIDS and other sexually transmitted diseases, illness from potential agents of bioterrorism, tuberculosis, malaria, autoimmune disorders, asthma and allergies.

Reference: M Altfeld et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 240:434-39 (2002).

Anne Oplinger | EurekAlert!
Further information:
http://www.niaid.nih.gov/

More articles from Health and Medicine:

nachricht The genes are not to blame
20.07.2018 | Technische Universität München

nachricht Targeting headaches and tumors with nano-submarines
20.07.2018 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Future electronic components to be printed like newspapers

A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.

The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

A smart safe rechargeable zinc ion battery based on sol-gel transition electrolytes

20.07.2018 | Power and Electrical Engineering

Reversing cause and effect is no trouble for quantum computers

20.07.2018 | Information Technology

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern

20.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>